Beneficient (NASDAQ:BENF – Get Free Report) is projected to announce its Q4 2026 resultson Tuesday, July 14th. Analysts expect Beneficient to announce earnings of ($1.63) per share and revenue of $12.8040 million for the quarter. Interested persons may visit the the company’s upcoming Q4 2026 earning report page for the latest details on the call scheduled for Monday, June 29, 2026 at 4:00 PM ET.
Beneficient Stock Performance
Shares of BENF opened at $3.63 on Tuesday. The firm’s fifty day simple moving average is $3.50 and its 200-day simple moving average is $4.16. Beneficient has a twelve month low of $2.16 and a twelve month high of $12.48.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Beneficient in a report on Wednesday, June 24th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.
Institutional Trading of Beneficient
An institutional investor recently bought a new position in Beneficient stock. Jane Street Group LLC bought a new stake in Beneficient (NASDAQ:BENF – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 18,922 shares of the company’s stock, valued at approximately $133,000. Jane Street Group LLC owned about 0.14% of Beneficient as of its most recent filing with the Securities and Exchange Commission. 90.57% of the stock is currently owned by hedge funds and other institutional investors.
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. The company offers Ben AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks, and complete their transactions with standardized transaction agreements.
See Also
- Five stocks we like better than Beneficient
- How TeraWulf’s Anthropic Deal Booted Up a $19B AI Empire
- Small-Cap ETFs Poised for Big Growth as Rate Outlook Shifts
- Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore
- As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
